Skip to main content
Log in

Transfer of labetalol into amniotic fluid and breast milk in lactating women

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The transfer of labetalol into human breast milk and amniotic fluid was studied in women with pregnancy hypertension. The women were treated with labetalol 600–1200 mg daily. The ratio between the areas under the milk and plasma concentration versus time curves varied between 0.8 and 2.6. No consistent relation between milk and plasma concentration in the mother was observed either within the individuals during a dose interval or between different individuals. One of the nursed infants at the end of the dose interval had a plasma labetalol in the same range as the mother, and in another infant the level was below the detection limit. Amniotic fluid concentrations 2–3 h after dosing were generally lower than in plasma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Fidler J, Smith V, de Swiet M (1983) Excretion of oxprenolol and trinolol in breast milk. Br J Obstet Gynaecol 90: 961–965

    Google Scholar 

  • Johnson G, Regårdh CG (1976) Clinical pharmacokinetics of beta-adrenoceptor blocking drugs. Clin. Pharmacokinet 1: 233–263

    Google Scholar 

  • Koch G (1977) Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients. Am Heart J 93: 585

    Google Scholar 

  • Kulas J, Lunell NO, Rosing U, Steen B, Rane A (1984) Atenolol and metoprolol: Comparison of their excretion into human breast milk. Acta Obstet Gynaecol Scand (Suppl) 118: 65–69

    Google Scholar 

  • Lunell NO, Hjemdahl P, Fredholm BB (1981) Circulatory and metabolic effects of a combined alpha- and beta-blocker (labetalol) in hypertension of pregnancy. Br J Clin Pharmacol 12: 345–348

    Google Scholar 

  • Melander A, Niklasson B, Ingemarsson I, Liedholm H, Schersten B, Sjöberg NO (1978) Transplacental passage of atenolol in man. Eur J Clin Pharmacol 14: 93–94

    Google Scholar 

  • Michael CA (1982) The evaluation of labetalol in the treatment of hypertension complicating pregnancy. Br J Clin Pharmacol 13: 127S-131S

    Google Scholar 

  • Richards DA, Prichard BNC (1979) Clinical pharmacology of labetalol Br J Clin Pharmacol 8: 89S-93S

    Google Scholar 

  • Riley A (1980) Some further evidence for partial agonist activity of labetalol. Br J Clin Pharmacol 9: 517–518

    Google Scholar 

  • Sandström B, Regårdh CG (1980) Metoprolol excretion into breast milk. Br J Clin Pharmacol 9: 518–519

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lunell, N.O., Kulas, J. & Rane, A. Transfer of labetalol into amniotic fluid and breast milk in lactating women. Eur J Clin Pharmacol 28, 597–599 (1985). https://doi.org/10.1007/BF00544073

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00544073

Key words

Navigation